LensGen
Founded Year
2011Stage
Series B | AliveTotal Raised
$41.15MLast Raised
$10M | 2 yrs agoAbout LensGen
LensGen is developing Juvene, a modular, fluid-optic accommodating intraocular lens which is designed with the potential to permanently restore clear and continuous vision at all distances for patients with cataracts and presbyopia. The lens provides accommodation by mimicking the eye's natural accommodation process to change shape and adjust focus, like the autofocus of a camera. The lens is implanted using current surgical techniques used for traditional intraocular lenses.
LensGen's Product Videos
Compete with LensGen?
Ensure that your company and products are accurately represented on our platform.
LensGen's Products & Differentiators
Juvene
Premium intraocular lens (IOL)
Expert Collections containing LensGen
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
LensGen is included in 2 Expert Collections, including Medical Devices.
Medical Devices
9,018 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,901 items
LensGen Patents
LensGen has filed 25 patents.
The 3 most popular patent topics include:
- Eye surgery
- Ophthalmology
- Vision
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
7/1/2021 | 10/18/2022 | Ophthalmology, Vision, Eye surgery, Corrective lenses, Diseases of the eye and adnexa | Grant |
Application Date | 7/1/2021 |
|---|---|
Grant Date | 10/18/2022 |
Title | |
Related Topics | Ophthalmology, Vision, Eye surgery, Corrective lenses, Diseases of the eye and adnexa |
Status | Grant |
Latest LensGen News
Nov 30, 2021
The post LensGen gets FDA nod for Juvene intraocular lens trial appeared first on NS Medical Devices.
LensGen Frequently Asked Questions (FAQ)
When was LensGen founded?
LensGen was founded in 2011.
Where is LensGen's headquarters?
LensGen's headquarters is located at 6 Jenner, Irvine.
What is LensGen's latest funding round?
LensGen's latest funding round is Series B.
How much did LensGen raise?
LensGen raised a total of $41.15M.
Who are the investors of LensGen?
Investors of LensGen include HOYA, Relativity Healthcare Partners, Rahul Harkawat, Amir Banifatemi, K5 Ventures and 3 more.
Who are LensGen's competitors?
Competitors of LensGen include Alcon.
What products does LensGen offer?
LensGen's products include Juvene.
Compare LensGen to Competitors
Ophthorobotics provides a solution for the delivery of intravitreal injections to treat chronic ocular diseases.
GlaucoT is a healthcare and biotechnology company that develops a neuroprotective glaucoma treatment with non-drug and non-invasive techniques. The company was founded in 2019 and is based in Istanbul, Turkey.
Alcon (SIX/NYSE: ALC) develops, manufactures, and markets pharmaceuticals, surgical equipment, and devices. It provides contact lenses and other vision care products. Alcon also helps people to get rid of certain diseases, such as presbyopia, and dry eye, and also helps people who are blind from cataracts. The company was founded in 1945 and is based in Fort Worth, Texas.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.